Ritleng®+ And Ritleng®+ PVP
Lacrimal Stents And Intubation Sets
FCI (France Chirurgie Instrumentation) SAS
The following data is part of a premarket notification filed by Fci (france Chirurgie Instrumentation) Sas with the FDA for Ritleng®+ And Ritleng®+ Pvp.
Pre-market Notification Details
| Device ID | K201892 |
| 510k Number | K201892 |
| Device Name: | Ritleng®+ And Ritleng®+ PVP |
| Classification | Lacrimal Stents And Intubation Sets |
| Applicant | FCI (France Chirurgie Instrumentation) SAS 20-22 Rue Louis Armand Paris, FR 75015 |
| Contact | Thierry Fetick |
| Correspondent | Barbara S. Fant Clinical Research Consultants, Inc. 3308 Jefferson Avenue, Upper Level Cincinnati, OH 45220 |
| Product Code | OKS |
| CFR Regulation Number | 510(k) Premarket Notification [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2020-07-08 |
| Decision Date | 2021-03-11 |
Trademark Results [Ritleng]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RITLENG 79202503 5238908 Live/Registered |
FRANCE CHIRURGIE INSTRUMENTATION SAS 2016-10-25 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.